China already has anti-coronavirus drugs on the market

The China National Administration of Health Products has authorized the sale of a new strain of corona virus called Favilavir. An anti-malarial drug has also been added to the treatment regimen for COVID-19 patients in China.

According to China Daily on February 17, this information was issued by the Taizhou City Government of Zhejiang Province on February 16.

A man recovered from COVID-19 donated plasma to scientists as a basis for research on how to treat the disease - (Image: REUTERS).

Favilavir, also known as Fapilavir, has been shown to be effective in treating patients with acute respiratory infections caused by the new strain of coronavirus (COVID-19). It is the first new corona-based anti-virus product to be licensed in China .

Favilavir was developed by Zhejiang Hisun Pharmaceutical Company and is one of three drugs that have shown marked efficacy in treatment, the Ministry of Science and Technology said.

The first batch of drugs started being produced on February 16 and is expected to soon appear in the market, helping to prevent disease and increase the rate of successful cure.

In related developments, on February 17, Xinhua reported that a drug to treat malaria would also be added to guidelines for treating patients with new coronary virus infection based on clinical trial results. .

Speaking at a press conference on February 17, Ms. Sun Yanrong - deputy director of the China Center for Biotechnology Development of the Ministry of Science and Technology - said health experts had agreed to give Chloroquine Phosphate. into the COVID-19 treatment regimen and will soon bring the drug into clinical trials as soon as possible.

According to Sun Yanrong, Chloroquine Phosphate has been selected among tens of thousands of existing drugs and screened dozens of times before being tested. This is the drug to treat malaria used for over 70 years.

Sun Yanrong added that the drug is currently being used at 10 hospitals in Beijing, as well as in Guangdong and Hunan provinces of China.

The trial process involved 100 patients and the group of patients treated with Chloroquine Phosphate drugs had a clear progress such as fever reduction, improved pulmonary images .

This group of patients also had faster recovery time and did not have any obvious serious side effects when using the medication.

• How new corona virus wreaks havoc on body parts?
• People with corona first cure Remdesivir from the disease
• Using a method different from traditional, the US company announced that it had found a vaccine for Covid-19
• Habits make men have higher rates of infection and death from Corona virus than women